Earlier studies indicate that chronic administration of galanin into the paraventricular nucleus of the hypothalamus leads to intricate alterations in daily caloric intake, levels of obesity, and regional fat deposition, depending on the fat and carbohydrate content of the diet [84]. The gene discussed is GAL; the disease is obesity disorder.